Muenzel, Thomas; Molitor, Michael; Kuntic, Marin et al.
Transportation Noise Pollution and Cardiovascular HealthCIRCULATION RESEARCH. Bd. 134. H. 9. 2024 S. 1113-1135
Wilms, Miriam; Jenetzky, Ekkehart; Maerzheuser, Stefanie et al.
Treatment of Anorectal Malformations in German Hospitals: Analysis of National Hospital Discharge Data from 2016 to 2021EUROPEAN JOURNAL OF PEDIATRIC SURGERY. Bd. 34. H. 06. 2024 S. 501-511
Wilms, Miriam; Maerzheuser, Stefanie; Jenetzky, Ekkehart et al.
Treatment of Hirschsprung's Disease in Germany: Analysis of National Hospital Discharge Data From 2016 to 2022JOURNAL OF PEDIATRIC SURGERY. Bd. 59. H. 10. 2024
Stege, Henner; Haist, Maximilian; Schultheis, Michael et al.
Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in GermanyJOURNAL OF CLINICAL MEDICINE. Bd. 13. H. 16. 2024
Winter, Y.; Sandner, K.; Bassetti, C. et al.
TREATMENT OF NARCOLEPSY BY MEANS OF VAGUS NERVE STIMULATIONSLEEP MEDICINE. Bd. 115. 2024 S. 228-228
Ayuk, Francis; Wagner-Drouet, Eva-Maria; Wolff, Daniel et al.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA studyBONE MARROW TRANSPLANTATION. Bd. 59. H. 8. 2024 S. 1092-1096
Keric, Naureen; Krenzlin, Harald; Kalasauskas, Darius et al.
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomasJOURNAL OF NEURO-ONCOLOGY. Bd. 167. H. 1. 2024 S. 133-144
Mengler, Katharina; Garbade, Sven F.; Gleich, Florian et al.
Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn ScreeningPEDIATRICS. Bd. 154. H. 2. 2024
Chaudhuri, Nazia; Spagnolo, Paolo; Valenzuela, Claudia et al.
Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional surveyRESPIRATORY RESEARCH. Bd. 25. H. 1. 2024
Galle, Peter; Finn, Richard S.; Mitchell, Catherine Ruth et al.
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic reviewJOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 12. H. 1. 2024